Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Huddart

Showing results (51-60 of 111) with videos related to

Pageof 12
Sort By:
European Urology Open Science|March 4, 2025
Meta-analysis of Germline Whole-exome Sequencing in 1435 Cases of Testicular Germ Cell Tumour to Evaluate Disruptive Mutations Under Dominant, Recessive, and X-linked Inheritance ModelsZeid Kuzbari, Charlie F Rowlands, Isaac Wade, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 30, 2019
Patterns of recurrence after prostate bed radiotherapyDouglas H Brand, Joanna I Parker, David P Dearnaley, et al.
The Lancet. Oncology|February 4, 2021
Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trialsAnanya Choudhury, Nuria Porta, Emma Hall, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2017
Clinical Outcomes of Image Guided Adaptive Hypofractionated Weekly Radiation Therapy for Bladder Cancer in Patients Unsuitable for Radical TreatmentShaista Hafeez, Fiona McDonald, Susan Lalondrelle, et al.
European Urology Open Science|September 15, 2023
Prechemotherapy Not Preorchiectomy Serum Tumor Markers Accurately Identify International Germ Cell Cancer Collaborative Group Prognostic Groups in NonseminomaChristian D Fankhauser, Abolghassem Jandari, Laurence Collette, et al.
European Urology|January 6, 2020
The 111 Study: A Single-arm, Phase 3 Trial Evaluating One Cycle of Bleomycin, Etoposide, and Cisplatin as Adjuvant Chemotherapy in High-risk, Stage 1 Nonseminomatous or Combined Germ Cell Tumours of the TestisMichael Cullen, Robert Huddart, Johnathan Joffe, et al.
BMC Cancer|September 19, 2023
Evaluating atezolizumab in patients with urinary tract squamous cell carcinoma (AURORA): study protocol for a single arm, open-label, multicentre, phase II clinical trialSimon Crabb, Robin Wickens, Sarah Jane-Bibby, et al.
European Urology|May 16, 2022
Chemoradiotherapy in Muscle-invasive Bladder Cancer: 10-yr Follow-up of the Phase 3 Randomised Controlled BC2001 TrialEmma Hall, Syed A Hussain, Nuria Porta, et al.
Plos Medicine|November 13, 2019
Testosterone replacement in young male cancer survivors: A 6-month double-blind randomised placebo-controlled trialJennifer S Walsh, Helen Marshall, Isabelle L Smith, et al.
The Lancet. Oncology|March 18, 2008
Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort studyRoy Vergis, Catherine M Corbishley, Andrew R Norman, et al.
Pageof 12

Showing results (51-60 of 111) with videos related to

Sort By:
Pageof 12
European Urology Open Science|March 4, 2025
Meta-analysis of Germline Whole-exome Sequencing in 1435 Cases of Testicular Germ Cell Tumour to Evaluate Disruptive Mutations Under Dominant, Recessive, and X-linked Inheritance ModelsZeid Kuzbari, Charlie F Rowlands, Isaac Wade, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 30, 2019
Patterns of recurrence after prostate bed radiotherapyDouglas H Brand, Joanna I Parker, David P Dearnaley, et al.
The Lancet. Oncology|February 4, 2021
Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trialsAnanya Choudhury, Nuria Porta, Emma Hall, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2017
Clinical Outcomes of Image Guided Adaptive Hypofractionated Weekly Radiation Therapy for Bladder Cancer in Patients Unsuitable for Radical TreatmentShaista Hafeez, Fiona McDonald, Susan Lalondrelle, et al.
European Urology Open Science|September 15, 2023
Prechemotherapy Not Preorchiectomy Serum Tumor Markers Accurately Identify International Germ Cell Cancer Collaborative Group Prognostic Groups in NonseminomaChristian D Fankhauser, Abolghassem Jandari, Laurence Collette, et al.
European Urology|January 6, 2020
The 111 Study: A Single-arm, Phase 3 Trial Evaluating One Cycle of Bleomycin, Etoposide, and Cisplatin as Adjuvant Chemotherapy in High-risk, Stage 1 Nonseminomatous or Combined Germ Cell Tumours of the TestisMichael Cullen, Robert Huddart, Johnathan Joffe, et al.
BMC Cancer|September 19, 2023
Evaluating atezolizumab in patients with urinary tract squamous cell carcinoma (AURORA): study protocol for a single arm, open-label, multicentre, phase II clinical trialSimon Crabb, Robin Wickens, Sarah Jane-Bibby, et al.
European Urology|May 16, 2022
Chemoradiotherapy in Muscle-invasive Bladder Cancer: 10-yr Follow-up of the Phase 3 Randomised Controlled BC2001 TrialEmma Hall, Syed A Hussain, Nuria Porta, et al.
Plos Medicine|November 13, 2019
Testosterone replacement in young male cancer survivors: A 6-month double-blind randomised placebo-controlled trialJennifer S Walsh, Helen Marshall, Isabelle L Smith, et al.
The Lancet. Oncology|March 18, 2008
Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort studyRoy Vergis, Catherine M Corbishley, Andrew R Norman, et al.
Pageof 12